The aquamantys system-an alternative to reduce blood loss in primary total hip arthroplasty?

Journal of Arthroplasty

Volumn 25, Issue 7, 2010, Pages 1072-1077

  Zeh, Alexander ^a   Messer, Jana ^a   Davis, John ^b   Vasarhelyi, Attila ^a   Wohlrab, David ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAMANTYS SYSTEM; ARTICLE; BIPOLAR SEALER; BLOOD VOLUME; CAUTERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SURGICAL EQUIPMENT; TOTAL HIP PROSTHESIS;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; COST-BENEFIT ANALYSIS; ELECTROCOAGULATION; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOSTASIS, SURGICAL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77957279503     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2009.10.008     Document Type: Article

References (28)

1. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43:459.
2. Hays M.B., Mayfield J.F. Total blood loss in major joint arthroplasty. A comparison of cemented and noncemented hip and knee operations. J Arthroplasty 1988, 3(Suppl):S47.
3. Johansson T., Engquist M., Pettersson L.G., et al. Blood loss after total hip replacement: a prospective randomized study between wound compression and drainage. J Arthroplasty 2005, 20:967.
4. Sturdee S.W., Beard D.J., Nandhara G., et al. Decreasing the blood transfusion rate in elective hip replacement surgery using an autologous drainage system. Ann R Coll Surg Engl 2007, 89:136.
5. Claeys M.A., Vermeersch N., Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007, 107:397.
6. Ekback G., Axelsson K., Ryttberg L., et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000, 91:1124.
7. Harley B.J., Beaupre L.A., Jones C.A., et al. The effect of epsilon aminocaproic acid on blood loss in patients who undergo primary total hip replacement: a pilot study. Can J Surg 2002, 45:185.
8. Locher S., Kuhne R., Lottenbach M., et al. Blood loss in total hip prosthesis implantation: lateral versus supine position. Z Orthop Ihre Grenzgeb 1999, 137:148.
9. Nelson C.L., Fontenot H.J. Ten strategies to reduce blood loss in orthopedic surgery. Am J Surg 1995, 170:64S.
10. Smith L.K., Williams D.H., Langkamer V.G. Post-operative blood salvage with autologous retransfusion in primary total hip replacement. J Bone Joint Surg Br 2007, 89:1092.
11. Wang G.J., Goldthwaite C.A., Burks S., et al. Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 2003, 13:399.
12. Grosvenor D., Goyal V., Goodman S. Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units. J Bone Joint Surg Am 82-A 2000, 951.
13. Hipp E.G., Plötz W., Thiemel G. Orthopädie und Traumatologie 2003, Georg Thieme, Stuttgart.
14. Marulanda G.A., Ragland P.S., Mont M.A. Use of a bipolar sealer device for hemostasis in total hip arthroplasty. Podium Presentaion AAOS 2006, Paper No: 382 (abstract).
15. Marulanda G.A., Ragland P.S., Seyler T.M., et al. Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Technol Int 2005, 14:281.
16. Ireland P.H. Randomized, prospective trial to examine the hemostatic efficiency of a bipolar sealer device for hemostasis in total hip arthroplasty. Poster Presentation AAOS 2006, Poster No: P177 (abstract).
17. Marulanda G.A., Ulrich S.D., Seyler T.M., et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008, 5:125.
18. Wohlrab D., Hagel A., Hein W. Advantages of minimal invasive total hip replacement in the early phase of rehabilitation. Z Orthop Ihre Grenzgeb 2004, 142:685.
19. Bauer R., Kerschbaumer F., Poisel S., et al. The transgluteal approach to the hip joint. Arch Orthop Trauma Surg 1979, 95:47.
20. Johansson T., Lisander B., Ivarsson I. Mild hypothermia does not increase blood loss during total hip arthroplasty. Acta Anaesthesiol Scand 1999, 43:1005.
21. Nadler S.B., Hidalgo J.U., Bloch T. Prediction of blood volume in normal human adults. Surgey 1961, 51:224.
22. Chin S.P., Abou-Madi M.N., Eurin B., et al. Blood loss in total hip replacement: extradural v. phenoperidine analgesia. Br J Anaesth 1982, 54:491.
23. Lemay E., Guay J., Cote C., et al. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004, 51:31.
24. Murkin J.M., Haig G.M., Beer K.J., et al. Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement. J Bone Joint Surg Am 2000, 82:675.
25. Rosenberg A.G. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplasty 2007, 22:82.
26. Wittmann F.W. Blood loss associated with uncemented total hip replacement: hypotension does not affect blood loss. J R Soc Med 1987, 80:213.
27. Vavken P., Kotz R., Dorotka R. Minimally invasive hip replacement-a meta-analysis. Z Orthop Unfall 2007, 145:152.
28. Gombotz H., Rehak P.H., Shander A., et al. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007, 47:1468.